Pharmacological evaluation of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, as potential anti-metastatic agent

De Leval, X.; Dassesse, T.; Benoit, V.; Pirotte, Bernard; David, Jean-Louis; Merville, Marie-Paule; Castronovo, Vincenzo; Dogné, Jean-Michel

Paper published in a journal (Scientific congresses and symposiums)

De Leval, X.; Dassesse, T.; Benoit, V. et al.

2003 • In Blood, p. 72

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/21964

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

abstract Blood 2003 3.pdf

Publisher postprint (168.23 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Pharmacy, pharmacology & toxicology

Author, co-author :

De Leval, X.

Dassesse, T.

Benoit, V.

Pirotte, Bernard ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique

David, Jean-Louis ; Université de Liège - ULiège > Médecine nucléaire - Hématologie clinique

Merville, Marie-Paule ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale

Castronovo, Vincenzo ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie générale et cellulaire - GIGA-R : Labo de recherche sur les métastases

Dogné, Jean-Michel

Language :

English

Title :

Pharmacological evaluation of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, as potential anti-metastatic agent

Publication date :

2003

Audience :

International

Journal title :

Blood

ISSN :

0006-4971

eISSN :

1528-0020

Publisher :

American Society of Hematology, Washington, United States - District of Columbia

Special issue title :

102

Pages :

72b

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 11 September 2009

Statistics

Number of views

51 (7 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics